首页|茵栀黄颗粒治疗3 610例黄疸患者的真实世界临床联合用药特征分析

茵栀黄颗粒治疗3 610例黄疸患者的真实世界临床联合用药特征分析

扫码查看
目的 对真实世界进行定向数据挖掘,针对茵栀黄颗粒治疗黄疸的临床方案特征进行分析,探索茵栀黄颗粒治疗黄疸的联合用药方案.方法 从真实世界15 家医院信息系统(hospital information system,HIS)中提取 3 610 例使用茵栀黄颗粒治疗黄疸患者的个人、住院及用药情况,标准化数据后以关联规则数据挖掘方式得出临床中使用茵栀黄颗粒治疗黄疸的联合用药方案;结果 3 610 例患者各年龄段均有发病,以45~65 岁占比最多(1 242 例,占 34.40%),均为男性多于女性.联合用药情况:茵栀黄颗粒主要联用西药胸腺肽、地塞米松、甘草酸、苯巴比妥、奥美拉唑、中药柴胡注射液、感冒清热颗粒、苦黄注射液、康复新液、结核丸,用药类别为西药抗菌药、肝胆疾病治疗药、免疫促进药,中药解表剂、清热剂、扶正剂.常见一般性黄疸治疗用药方案:茵栀黄颗粒+苦黄注射液+甘草酸;茵栀黄颗粒+甘草酸+胸腺肽+苦黄注射液;抗结核药物相关肝损害所致黄疸协同治疗用药方案:茵栀黄颗粒+结核丸+康复新液+乙胺丁醇;茵栀黄颗粒+吡嗪酰胺+利福平+乙胺丁醇+康复新液;常见的用药类别联合方案:茵栀黄颗粒+清热剂+肝、胆疾病治疗药;茵栀黄颗粒+肝、胆疾病治疗药+免疫促进药+抗菌药+清热剂;茵栀黄颗粒+解表剂+清热剂+抗菌药;茵栀黄颗粒+扶正剂+解表剂+清热剂+抗菌药.结论 治疗一般性黄疸,临床常采用的治疗方案为茵栀黄颗粒联合苦黄注射液+甘草酸和茵栀黄颗粒联合苦黄注射液+甘草酸+胸腺肽;对于长期服用抗结核药物引起的黄疸,常用的治疗方案为茵栀黄颗粒联合结核丸+康复新液+乙胺丁醇和茵栀黄颗粒联合吡嗪酰胺+利福平+乙胺丁醇+康复新液.
Analysis of the Characteristics of Real World Clinical Drug Combination in 3 610 Patients with Jaundice Treated with Yinzhihuang Granules
Objective Directional data mining was carried out for the real world,and the clinical scheme characteristics of Yinzhihuang granules in the treatment of jaundice were analyzed to explore the combined medication scheme of Yinzhihuang granules in the treatment of jaundice.Methods The personal,hospitalization and drug use of 3 610 patients with jaundice treated with Yinzhihuang granules were extracted from 15 hospital information systems(HIS)in the real world.After standardizing the data,the combined drug scheme of Yinzhihuang granules in the treatment of jaundice was obtained by association rule data mining.Results The 3 610 patients of each age had the onset,which largest proportion 45-65 years old(1 242 cases,34.40%)and were more men than women.Combined medication:Yinzhihuang granules mainly use with Chinese and western medicine thymopeptide,dexamethasone,glycyrrhizic acid,phenobarbital,omeprazole,bupleurum injection,Ganmao Qingre granules,Kuhuang injection,Kangfuxin solution,Jiehe pills,drug type for western medicine antibacterial,hepatobiliary disease treatment,immune promotion,Chinese medicine diaphoretic recipes,heat clearing agent,forming agent.Common general jaundice treatment regimen:Yinzhihuang granules+Kuhuang injection+ glycyrrhizic acid,Yinzhihuang granules+glycyrrhizic acid+thymopeptide+Kuhuang injection.Collaborative treatment of jaundice caused by anti-tuberculosis drug-related liver damage:Yinzhihuang granules+Jiehe pills+Kangfuxin solution+ ethambutol,Yinzhihuang granules+pyrazinamide+rifampicin+ethambutol+Kangfuxin solution.Common drug types of joint program:Yinzhihuang granules+heat clearing agent+liver and bile disease treatment drugs,Yinzhihuang granules+ liver,biliary disease treatment drugs+immune promotion drugs+antibacterial drugs+heat clearing agent.Yinzhihuang granules+diaphoretic recipes+heat clearing agent+antibacterial drugs.Yinzhihuang granules+forming agent+diaphoretic recipes+heat clearing agent+antibacterial drugs.Conclusion For treating general jaundice,the clinical treatment scheme often used is Yinzhihuang granules with Kuhuang injection+glycyrrhizic acid and Yinzhihuang granules with Kuhuang injection+glycyrrhizic acid+thymopeptide;for jaundice caused by long-term use of anti-tuberculosis drugs,the commonly used treatment scheme is Yinzhihuang granules combined with Jiehe pills + Kangfuxin solution + ethambutol and Yinzhihuang granules combined with pyrazinamide+rifampin+ethambutol+Kangfuxin solution.

Real worldYinzhihuang granulesJaundiceCombination medicationHIS

熊文娟、杨恺瑞、张成、庄严、谢雁鸣

展开 >

中国中医科学院中医临床基础医学研究所,北京 100700

中国中医科学院西苑医院,北京 100091

中国人民解放军海军总医院,北京 100048

真实世界 茵栀黄颗粒 黄疸 联合用药 HIS

国家重点研发计划

2018YFC1707400

2024

中国中医基础医学杂志
中国中医研究院基础理论研究所

中国中医基础医学杂志

CSTPCD
影响因子:0.779
ISSN:1006-3250
年,卷(期):2024.30(5)
  • 37